Description
VIP (Vasoactive Intestinal Peptide) is a 28-residue neuropeptide prepared by solid-phase peptide synthesis, carrying the mammalian VIP(1-28) sequence with a C-terminal amide. Its 28 residues adopt an extended alpha-helical segment that docks into the extracellular domain of its receptors, while the N-terminal residues insert into the transmembrane bundle to drive receptor activation. The C-terminal amide is required for full activity at the receptor.
Compound Specifications
| Synonyms | VIP, VIP(1-28), vasoactive intestinal polypeptide |
| Sequence (one-letter) | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH₂ |
| Sequence Length | 28 residues |
| Terminal Modifications | Free N-terminus; C-terminal amide at Asn28 |
| Molecular Formula | C₁₄₇H₂₃₈N₄₄O₄₂S |
| Molecular Weight | 3325.8 g/mol |
| Monoisotopic Mass | 3323.756 Da |
| CAS Number | 40077-57-4 |
Storage & Handling
Store the lyophilized powder in a sealed container at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and use it promptly. Avoid repeated freeze–thaw cycles. Use aseptic technique to preserve compound integrity and follow standard laboratory safety practices.
FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

